큐리진

kor

kor

kor

kor

준비중입니다

준비중입니다

준비중입니다

2024

04Technology transfer of the 'CA102' pipeline of Curigin anticancer gene therapy paper
Chong Kun Dang
04Joint Research Agreement Enters For Bispecific RNAi Platform Technology
LG Chemical

2023

07Merck Life Sciences Wins Contest to Discover Promising Bio Startups
07[Grnat] Gene editing, control, and restoration based technology development (R&D)
Korea Research Foundation
04[Grant] 2023 National New Drug Development Project (R&D)
National New Drug Development Project Group

2022

03[Grant] National New Drug Development Task
National New Drug Development Project Group
01[Grant] Big3 Innovation Start-up Package
Business Start-up Promotion Agency

2021

09[Grant] Bio·Medical Technology
-Seoul Business Agency-
04[Bridge Funding] Investment
LB Investment, Company K Partners, Hana Financial Investment, Time Folio, Wooshin
01Technical Research Personnel Company
Korea Military Manpower Administration

2020

07[Grant] Unicorn 200
Korea Ministry of SMEs and Startups
06[Grant] Big3 venture
Korea Ministry of SMEs and Startups
04[Grant] Investment-linked growth supporting
Korea Ministry of Science and ICT

2019

05[Series A] Investment
KIP(Korea Investment Partners), DSC Investment, Schmidt
03Curigin headquarter relocation
Seongdong-gu, Seoul forest

2018

05Registered as trademarks
03Certification Company R&D Center
03[Pre-A] Investment
KIP(Korea Investment Partners, DSC Investment

2016

03Approved as a ‘Venture company’
02Foundation of Curigin co., Ltd.